• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Technol Health Care . Prediction and follow-up of risk factors for severe SARS-CoV-2 pneumonia and application of CT visual scoring

tetano

Editor, Senior Moderator
Technol Health Care


. 2021 Feb 26.
doi: 10.3233/THC-218016. Online ahead of print.
Prediction and follow-up of risk factors for severe SARS-CoV-2 pneumonia and application of CT visual scoring


Yingjian Ye[SUP] 1 1 [/SUP], Xiaxia Wu[SUP] 2 1 [/SUP], Xiumei Li[SUP] 1 [/SUP], Chunmei Xu[SUP] 1 [/SUP], Qingpeng Wang[SUP] 3 [/SUP], Wenhuan Yuan[SUP] 4 [/SUP], Li Zhang[SUP] 5 [/SUP], Huan Li[SUP] 6 [/SUP], Lishi Zheng[SUP] 6 [/SUP], Qiongxia Li[SUP] 1 [/SUP], Zhibing He[SUP] 2 [/SUP], Bo Liu[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The SARS-CoV-2 pneumonia infection is associated with high rates of hospitalization and mortality and this has placed healthcare systems under strain. Our study provides a novel method for the progress prediction, clinical treatment and prognosis of NCP, and has important clinical value for timely treatment of severe NCP patients.
Objective: To summarize the clinical features and severe illness risk factors of the patients with novel coronavirus pneumonia (NCP), in order to provide support for the progression prediction, clinical treatment and prognosis of NCP patients.
Materials and methods: A total of 196 NCP patients treated in our hospital from January 25, 2020 to June 21, 2020 were divided into the severe group and the mild group. The clinical features of the two groups were analyzed and compared. The risk factors were explored by using multivariate logistic regression, and the receiver operating characteristic (ROC) curve was obtained. The correlations of the risk factors with the prognosis of NCP were investigated combined with the lung function test.
Results: The primary clinical symptoms of 196 cases of NCP included fever in 167 cases (85.2%) and cough in 121 cases (61.73%). The chest computed tomography (CT) scans of the 178 cases (90.81%) showed a typical ground-glass opacification. In 149 cases, the lymphocyte count was decreased, while the levels of creatine kinase (CK), lactate dehydrogenase (LDH), c-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and D-dimer (D-D) increased. 44 cases (22.45%) were found to be severely ill. The multivariate logistic regression analysis demonstrated that age, underlying disease, length of hospital stay, body mass index (BMI), LDH, chest CT visual score, absolute lymphocyte count (ALC) and CRP were risk factors for severe.
 
Back
Top Bottom